DNA X, Inc. SONM
$3.10
$0.082.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 72.56% | 51.21% | 38.61% | -149.38% | -200.96% |
| Total Depreciation and Amortization | -29.91% | -13.05% | 20.89% | 158.19% | 525.47% |
| Total Amortization of Deferred Charges | -77.38% | -68.28% | -68.11% | -19.07% | -19.07% |
| Total Other Non-Cash Items | -4,271.39% | -2,047.04% | -185.91% | -145.93% | -114.50% |
| Change in Net Operating Assets | 31.29% | 125.31% | -149.45% | 172.47% | 285.85% |
| Cash from Operations | 25.29% | 3.00% | -177.23% | -501.46% | -360.59% |
| Capital Expenditure | -- | -- | -- | 96.33% | -76.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2,351.03% | 1,925.00% | -- | 96.33% | -76.83% |
| Total Debt Issued | 92.83% | 24.22% | -- | -- | -- |
| Total Debt Repaid | 106.09% | -- | -- | -1,497.30% | -698.65% |
| Issuance of Common Stock | -48.57% | 34.42% | 237.14% | 264.17% | 115.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.29% | 19.48% | 319.41% | 401.86% | 186.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.44% | 87.11% | 0.35% | -839.35% | -6,228.33% |